BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI)
CUSIP: 09075P105
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 26,011,000
- Total 13F shares
- 4,179,707
- Share change
- +1,162,456
- Total reported value
- $29,412,098
- Price per share
- $7.04
- Number of holders
- 41
- Value change
- +$8,120,529
- Number of buys
- 27
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 09075P105?
CUSIP 09075P105 identifies BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075P105:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Artemis Investment Management LLP |
13F
|
Company |
3.8%
|
979,015
|
$10,644,000 | — | 30 Jun 2019 | |
| FMR LLC |
13F
|
Company |
2.7%
|
706,789
|
$7,746,000 | — | 30 Jun 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
299,145
|
$3,278,000 | — | 30 Jun 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
1.1%
|
298,400
|
$3,270,000 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
259,301
|
$2,842,000 | — | 30 Jun 2019 | |
| UBS Group AG |
13F
|
Company |
0.29%
|
75,562
|
$828,000 | — | 30 Jun 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
71,600
|
$785,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
60,443
|
$662,000 | — | 30 Jun 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
64,142
|
$526,000 | — | 30 Jun 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
43,822
|
$481,000 | — | 30 Jun 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
32,162
|
$352,000 | — | 30 Jun 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
18,083
|
$198,000 | — | 30 Jun 2019 | |
| Creative Planning |
13F
|
Company |
0.06%
|
16,000
|
$175,000 | — | 30 Jun 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
12,536
|
$138,000 | — | 30 Jun 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.04%
|
10,694
|
$117,000 | — | 30 Jun 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
9,282
|
$102,000 | — | 30 Jun 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
9,200
|
$101,000 | — | 30 Jun 2019 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.02%
|
5,000
|
$53,000 | — | 30 Jun 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
4,541
|
$49,000 | — | 30 Jun 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
3,886
|
$43,000 | — | 30 Jun 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
3,833
|
$42,000 | — | 30 Jun 2019 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0.01%
|
1,750
|
$19,000 | — | 30 Jun 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
1,706
|
$19,000 | — | 30 Jun 2019 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
1,683
|
$18,000 | — | 30 Jun 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
1,656
|
$18,000 | — | 30 Jun 2019 | |
| STRS OHIO |
13F
|
Company |
0.01%
|
1,600
|
$17,000 | — | 30 Jun 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,196
|
$14,000 | — | 30 Jun 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,005
|
$11,000 | — | 30 Jun 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
1,000
|
$11,000 | — | 30 Jun 2019 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
531
|
$6,000 | — | 30 Jun 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
376
|
$4,000 | — | 30 Jun 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
300
|
$3,000 | — | 30 Jun 2019 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0%
|
200
|
$2,000 | — | 30 Jun 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
91
|
$1,000 | — | 30 Jun 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
16
|
$175 | — | 30 Jun 2019 |
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) as of Q3 2019
As of 30 Sep 2019,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 (BTAI) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,179,707 shares.
The largest 10 holders included
Artemis Investment Management LLP, FMR LLC, VANGUARD GROUP INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BlackRock Inc., Point72 Asset Management, L.P., CVI Holdings, LLC, DAFNA Capital Management LLC, NORTHERN TRUST CORP, and STATE STREET CORP.
This page lists
41
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
34
Q3 2019 holders
41
Holder diff
7
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.